| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/24/2004 | US6780967 Metal chelate-labelled peptides |
| 08/24/2004 | US6780892 Polymeric hemoglobin mutants |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780847 Nucleotide sequences coding polypeptide for use in the treatment and prevention of viral infections |
| 08/24/2004 | US6780846 Membrane translocating peptide drug delivery system |
| 08/24/2004 | US6780845 Compounds and methods for cancer therapy |
| 08/24/2004 | US6780844 Calcium phosphopeptide complexes |
| 08/24/2004 | US6780837 Administering neurotrophic factor prior to, during or after damaging light exposure |
| 08/24/2004 | US6780630 Comprises live and inactivated vaccines; immunogens; for human and animal infants |
| 08/24/2004 | US6780625 Glycogen synthase kinase-3 inhibitors |
| 08/24/2004 | US6780624 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 08/24/2004 | US6780615 Comprises endogenous signal sequence of pichia pastoris phosphatase, proteinase, and carboxypeptidase; increased sweetness in comparison to sucrose |
| 08/24/2004 | US6780614 Modified factor VIII cDNA and its use for the production of factor VIII |
| 08/24/2004 | US6780613 For identifying active domains and amino acid residues in polypeptides; prolactins; placental lactogens |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780608 Comprises chimeric polypeptides with varying calcium/caffeine sensitivity; for drug screening |
| 08/24/2004 | US6780607 Generation of preferential proteins in cell free system; obtain cell extract, incubate with nucleotide sequences, expose to translational organelles, recover processed proteins |
| 08/24/2004 | US6780604 Nucleotide sequences wich code apoptosis protein for use in the treatment in cancer and proliferative defects |
| 08/24/2004 | US6780603 Altering gene expression for diagnosis |
| 08/24/2004 | US6780601 Nucleotide sequences coding polypeptide for use as insecticide |
| 08/24/2004 | US6780600 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 08/24/2004 | US6780599 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins |
| 08/24/2004 | US6780598 Method of identifying and locating immunobiologically-active linear peptides |
| 08/24/2004 | US6780595 Human Tbx20 gene and uses |
| 08/24/2004 | US6780586 Methods of diagnosing breast cancer |
| 08/24/2004 | US6780583 For detecting carriers of the defective gene |
| 08/24/2004 | US6780434 Controlled release of metal cation-stabilized interferon |
| 08/24/2004 | US6780420 Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine |
| 08/24/2004 | US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide |
| 08/24/2004 | US6780417 Transmission blocking immunogen from malaria |
| 08/24/2004 | US6780416 Bee venom polypeptides and methods of use thereof |
| 08/24/2004 | US6780410 Isolated cd39la polypeptide comprising specified amino acid sequence or mature protein portion thereof, having phosphohydrolase activity |
| 08/24/2004 | US6780408 Genes encoding hybrid bacillus thuringiensis toxins |
| 08/24/2004 | US6780407 Recombinant attenuated avipox virus containing exogenous dna in nonessential region, that expresses exogenous dna encoding carcinoembryonic antigen and exogenous dna encoding b7 protein |
| 08/24/2004 | CA2458824A1 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |
| 08/24/2004 | CA2173626C B1k chain of laminin and methods of use |
| 08/24/2004 | CA2116355C Infectious bovine rhinotracheitis virus mutants and vaccines |
| 08/24/2004 | CA2061148C Glia activating factor and its production |
| 08/19/2004 | WO2004070388A1 Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases |
| 08/19/2004 | WO2004070383A2 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis |
| 08/19/2004 | WO2004070351A2 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | WO2004070055A1 Dna markers for marbling |
| 08/19/2004 | WO2004070037A1 Inhibitors of staphylococcus aureus primary sigma factor and uses thereof |
| 08/19/2004 | WO2004070036A1 Protein and gene participating in perpetual blooming of angiosperm |
| 08/19/2004 | WO2004070035A2 Method for increasing efficiency of homologous recombination in plants |
| 08/19/2004 | WO2004070031A1 Plant-origin genes inducing cell death |
| 08/19/2004 | WO2004070028A1 Molting hormone receptor and method of screening ligand to the receptor |
| 08/19/2004 | WO2004070016A2 System for expression of genes in plants |
| 08/19/2004 | WO2004070015A2 Nematode pan and zp receptor-like sequences |
| 08/19/2004 | WO2004070004A2 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | WO2004069997A2 Method for the production of a composition of dna sequences or the expression products thereof permitting the identification of the strains of helicobacter pylori and use thereof in a prognostic or diagnostic method |
| 08/19/2004 | WO2004069993A2 Non-touch zona pellucida microdrilling of a single - cell embryo with a 1.48 um laser beam for introduction of retrovirus |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069874A1 Monoclonal antibodies against the ring surface protein 2 (rsp-2) antigen of plasmodium falciparum |
| 08/19/2004 | WO2004069873A2 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | WO2004069871A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | WO2004069870A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069868A1 Complex of telomere protein with guanine-quadruplex dna |
| 08/19/2004 | WO2004069867A2 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 08/19/2004 | WO2004069865A2 Control of plant growth and developmental processes |
| 08/19/2004 | WO2004069864A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 08/19/2004 | WO2004069863A2 Constrained hiv v3 loop peptides as immunogens and receptor antagonists |
| 08/19/2004 | WO2004069859A2 Restoring function to gonadotropin releasing hormone receptor mutants |
| 08/19/2004 | WO2004069298A1 Fgf-2 derived proteins for the preparation of biomaterials or medical devices such as stents |
| 08/19/2004 | WO2004069270A1 Immunoregulating compounds and an associated method |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |
| 08/19/2004 | WO2004069207A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069206A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069191A2 Identification of t1r and t2r modulators |
| 08/19/2004 | WO2004069184A2 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | WO2004069183A2 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | WO2004069178A2 Anti-inflammatory activity from lactic acid bacteria |
| 08/19/2004 | WO2004069176A2 Polymer conjugates of mutated neublastin |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069165A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/19/2004 | WO2004069163A2 Cross-protective epitopes of moraxella catarrhalis and use thereof |
| 08/19/2004 | WO2004069140A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 08/19/2004 | WO2004069136A2 Mucin-like polypeptides |
| 08/19/2004 | WO2004056863A3 Splice variant of human placental growth hormone |
| 08/19/2004 | WO2004050829A3 Recombinant double-stranded rna phage, and use of the same |
| 08/19/2004 | WO2004050702A3 Novel ifngamma-like polypeptides |
| 08/19/2004 | WO2004045540A3 Method for continuous, automated blending of solutions from acids and bases |
| 08/19/2004 | WO2004031234A3 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 08/19/2004 | WO2004031222A3 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 08/19/2004 | WO2004029075A3 Peptide nucleic acids having improved uptake and tissue distribution |
| 08/19/2004 | WO2004027067A3 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 08/19/2004 | WO2004024891A3 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004020452A3 Method for refolding neisserial nspa protein |
| 08/19/2004 | WO2004016651A3 Spider silk polypeptide |
| 08/19/2004 | WO2004007675A3 Neuronal and optic nerve gene expression patterns |
| 08/19/2004 | WO2004005480A3 Plastid genetic engineering via somatic embryogenesis |
| 08/19/2004 | WO2004004630A3 Osteoinductive biomaterials |
| 08/19/2004 | WO2003101388A3 Human solute carrier family 7 member 11 (hslc7a11) |
| 08/19/2004 | WO2003095663A3 Modified t lymphocytes and uses therefor |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003072750A3 Expression of hiv-related proteins in plants |
| 08/19/2004 | WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |